The CyberKnife® Radiosurgery Solution:
Early stage Bronchogenic Carcinoma: Overview
Stereotactic radiosurgery, sometimes also referred to in the literature as stereotactic radiotherapy, is a new technique that shows great promise in the treatment of early stage bronchogenic carcinomas in medically unresectable patients, with published local control rates approaching 100% in the higher dose arms, albeit with relatively short follow-up (10, 11,12, 13).CyberKnife® Technical Solutions:
CyberKnife® radiosurgery effectively addresses all of the technical limitations of standard radiotherapy described above, resulting in a very sophisticated method to deliver a far more biologically potent dose of radiation to an early stage bronchogenic carcinoma lesion, with surgical precision. Briefly, these include:
- Radiation Dose/Therapeutic Margin
- Respiratory Tumor Motion
- Virtually Unlimited Numberof Targeting Angles
|
